Thursday, June 30, 2022 8:18:49 AM
My suggestion price property in Southern California,purchasing pharmaceutical equipment, cost of FDA permits and licenses and certifications, professional, labor to install equipment, professionals to run and monitor equipment, purchase of active and inactive ingredients etc etc.
In the real world those things cost money.
$6000 dollars does not go very far.
3,000,000 dollars in sales does not give you enough collateral to borrow.
3,000,000 dollars in total revenue and 1.5 billion shares already in he OS will not encourage any one to invest for preferred or common shares.
There is only one option left, if they are going to do what they say they are going to do.
You know there will not be a RS because you know there will not be an acquisition, or them setting their own facility, of 14 new skus added, because they are not a manufacture but only a very tiny Private label company.
Recent SHMN News
- Shares of this BioPharma on a Tear as it Successfully Engineered a T-Cell From a Healthy Human Donor • AllPennyStocks.com • 06/10/2024 06:30:00 PM
- Gene Editing Company Joins Forces to Advance Gene Therapy • AllPennyStocks.com • 04/01/2024 03:46:00 PM
FEATURED Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM
BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM
CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • CBDL • Oct 8, 2024 8:00 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM